Our COMPANY vision
To be a recognised global leader in innovative near patient diagnostic testing, matching each patient’s critical condition to the right treatment at the right time.
Our Mission Statement
Answering a key challenge of health services worldwide by providing accurate, cost effective near patient testing which expedites patient care and significantly reduces costs.
Our Company Values
These are the practical things we believe in and they directly inform the decisions we make and actions taken to deliver our ‘Vision’.
Everything we do is directed to make sure that patients are in control and at the forefront of their medical care.
In order to support patients, we must support our B2B customers and address their business needs.
Our test development has to deliver accurate results. Working with our customers, we must ensure precision and clinical evidence of efficacy.
AGPLUS PLATFORM DEVLOPMENT
We are proud to have developed a tried and tested B2B commercial approach to Assay Development. We strive to progress partnerships including technology licensing, development plus manufacture and supply, with collaborators in a variety of applications and business sectors.
To work in conjunction with our proven assay development service, we are proud to have launched our diagnostic reader. The Agilis Reader provides a robust solution for gathering fast and quantitative data which is fully connected with a global network.